Cargando…
Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
BACKGROUND: The goal of mucoactive therapies in cystic fibrosis (CF) is to enhance sputum clearance and to reduce a progressive decline in lung function over the patient's lifetime. We aimed to investigate the level of consensus among specialists from Italian CF Centers on appropriateness of th...
Autores principales: | Volpi, Sonia, Carnovale, Vincenzo, Colombo, Carla, Raia, Valeria, Blasi, Francesco, Pappagallo, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169509/ https://www.ncbi.nlm.nih.gov/pubmed/35677472 http://dx.doi.org/10.1002/hsr2.604 |
Ejemplares similares
-
Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
por: Charrier, Cedric, et al.
Publicado: (2014) -
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
por: Scaglione, Francesco, et al.
Publicado: (2019) -
Clinical expression of cystic fibrosis in a large cohort of Italian siblings
por: Terlizzi, Vito, et al.
Publicado: (2018) -
Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2006) -
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
por: Yan, Xixin, et al.
Publicado: (2017)